Welcome, Guest |
|
TOPIC:
Options for retreatment 7 years 11 months ago #17027
Options for retreatment 7 years 11 months ago #17081
| Thats interesting info for us that have had a wobble on tx. Cheers Two time relapser. SVR 4 achieved 12/16 at last SVR 12 achieved 22/02/2017 The Bastard has been defeated GT 3 - about 28 yrs with HCV The following user(s) said Thank You: fitz |
Options for retreatment 7 years 10 months ago #17148
Thanks for posting this. Have been reading most all the material available online regarding HCV retreatment. The collection of work presented here by David Wyles MD at UCSD is interesting to be sure. From the perspective of a patient seeking retreatment – I view information such as this as very encouraging – though academic. Using the existing AASLD guidelines for initial therapy – medical coverage here in the States for approved HCV DAA medicines is often denied to patients without significant fibrosis scores. Following the new and current AASLD guidelines for retreatment – “deferral of treatment” is recommended for patients who do not have cirrhosis and do not have reasons for urgent retreatment. www.hcvguidelines.org/full-report/retrea...r-therapy-has-failed Most any retreatment plan using approved HCV medicines here will be unavailable through medical insurance with the existing guidelines and drug costs – emphasis on the latter. Using the flow chart shown above from Wyles’ presentation – the most basic retreatment option (no NS5A RAVs) calls for 24 weeks of Harvoni – current retail price here is just over $183,000 USD. The base retreatment option when some known NS5A RAVs are present calls for 24 weeks of Sovaldi and Olysio with ribavirin – current retail price here is over $305,000 USD. While government agencies and insurers have negotiated significant price discounts from the drug manufacturers – these reduced prices are not available to individual patients seeking treatment. Any realistic retreatment regiment is thereby limited to available generic medicines. This means that new drug studies – however promising – will only produce practical results sometime in the future when and if such medicines are manufactured as generics. Note that Olysio (simeprevir) – currently recommended for retreatment – has yet to become readily available as a generic. Crossing the first hurdle for treatment has only just recently become a reality for many with the availability of generics. The second hurdle for retreatment is somewhat higher making resources such as FixHepC and access to affordable generic medicines even more important. J GT 1a (~1968) Diagnosed Non A/B ’85 – HCV ‘89 Rebetron INF/RBV 17 months 2000 – Failure Infergen INF/RBV 11 months 2002 – Failure Viekira Pak + RBV 12 weeks 2015 – Failure VL Und at +3 weeks > EOT – EOT+12 weeks 2,240k Resistance Tests – NS5a Q30R SMV/DCV/SOF + RBV 24 weeks 2016 VL Det <15 +2 and +4 weeks – Und +8 weeks > EOT SVR4, SVR12 and SVR24 Undetected | |
Options for retreatment 7 years 8 months ago #20387
Any tests done for RAV? U are the first person i know relapsed on viekira pak. The following user(s) said Thank You: fitz | |
Options for retreatment 7 years 8 months ago #20389
For retreatment in GT1 DAA failures 3 drugs are better than 2. For 2 drugs Sof+Vel would be the current best choice. Options for 3D treatment include: Sof+Dac+Simeprevir (about $4500 for 12 weeks) Sof+Dac+Asunaprevir (about $3000 for 12 weeks) Or for those who can access branded meds via insurance Viekira pac + Sofosbuvir Zepatier + Sofosbuvir With the sofosbuvir as a generic for under $1000 for 12 weeks All can be +/- ribavirin for a 4th weaker agent. YMMV | |
Options for retreatment 7 years 8 months ago #20393
Yes TM ....
The SVR numbers for GT1a patients treated with Vieira Pak + RBV are reportedly very good - certainly on par with Harvoni from my understanding. Unfortunately - I fell into that few percent of patients that couldn't get it right the first time. Had HCV drug resistance testing performed after treatment by both Monogram Biosciences (LabCorp) and Quest Diagnostics (just NS5a for the latter). Results showed the presence of NS5a drug resistant Q30R - tested resistant/probable against all available DAA's with the exception of velpatasvir (test was unavailable at the time). From my reading - it appears that Q30R is likely resistant to velpatasvir as well. How each of these NS5a inhibitors perform against Q30R in practice - and when combined with other DAAs - is the subject of trials. Very fortunately - my tests showed no NS3/4a or NS5b RAVs - most importantly no NS3 Q80K that may have precluded retreatment with simeprevir. From my reading - prevalence or the Q80K RAV varies widely by geography with North America ranking at or near the top. Over one-third of GT1a patients here reportedly test positive for Q80K. Dr. Freeman has a post on the forum that discusses this: fixhepc.com/forum/experts-corner/1077-ge...een-gt-1a.html#17705 My apologies for the late response to your earlier post. J GT 1a (~1968) Diagnosed Non A/B ’85 – HCV ‘89 Rebetron INF/RBV 17 months 2000 – Failure Infergen INF/RBV 11 months 2002 – Failure Viekira Pak + RBV 12 weeks 2015 – Failure VL Und at +3 weeks > EOT – EOT+12 weeks 2,240k Resistance Tests – NS5a Q30R SMV/DCV/SOF + RBV 24 weeks 2016 VL Det <15 +2 and +4 weeks – Und +8 weeks > EOT SVR4, SVR12 and SVR24 Undetected | |
Options for retreatment 7 years 8 months ago #20428
U can use sof+sim+dac! (Possibly with riba also at the start of treatment to hit the virus hard) Don't give up! | |
Options for retreatment 7 years 8 months ago #20430
| You need to talk with Dr. Freeman, www.gp2u.com. He is the expert here. He will cure you. Gt 1a, F0, VL 6.5 million, AST 59, ALT 62 Started Twinvir 1/15/16 6 wk. labs VL UND, AST 27, ALT 20 EOT labs VL UND, AST 23, ALT 19 SVR 16, VL UND, AST 28, ALT 17 SVR 24 , VL UND, 10/8/16 SVR 125, VL UND, 9/22/18 SVR 230, VL UND, 10/3/20 |
Options for retreatment 7 years 20 hours ago #24338
Very good advice TM ....
SMV/DCV/SOF + RBV is one of the three retreatment options outlined in the 2016 EASL HCV Guidelines for those with GT1a who failed treatment with a regime containing an NS5a inhibitor (such as Viekira - PrOD). The other two recommended therapies are Merck's Zepatier GRZ/ELB + SOF + RBV and AbbVie's Viekira Pak PrOD + SOF + RBV. All three call for 24 weeks of therapy. Summarized in Table 9 / Page 36 www.easl.eu/medias/cpg/HCV2016/English-report.pdf I believe these EASL Guidelines became available online just after your post here. J GT 1a (~1968) Diagnosed Non A/B ’85 – HCV ‘89 Rebetron INF/RBV 17 months 2000 – Failure Infergen INF/RBV 11 months 2002 – Failure Viekira Pak + RBV 12 weeks 2015 – Failure VL Und at +3 weeks > EOT – EOT+12 weeks 2,240k Resistance Tests – NS5a Q30R SMV/DCV/SOF + RBV 24 weeks 2016 VL Det <15 +2 and +4 weeks – Und +8 weeks > EOT SVR4, SVR12 and SVR24 Undetected | |
Options for retreatment 7 years 20 hours ago #24339
Thanks GF .... I took your advice ....
J GT 1a (~1968) Diagnosed Non A/B ’85 – HCV ‘89 Rebetron INF/RBV 17 months 2000 – Failure Infergen INF/RBV 11 months 2002 – Failure Viekira Pak + RBV 12 weeks 2015 – Failure VL Und at +3 weeks > EOT – EOT+12 weeks 2,240k Resistance Tests – NS5a Q30R SMV/DCV/SOF + RBV 24 weeks 2016 VL Det <15 +2 and +4 weeks – Und +8 weeks > EOT SVR4, SVR12 and SVR24 Undetected | |
Options for retreatment 7 years 19 hours ago #24340
Thank you Dr. Freeman for all your help ....
Obtained the 24 week supply of DCV/SOF through the Redemption program. The SMV came as branded Olysio grey-market from other sources. Total price for the three DAA medicines delivered was just under $9000 USD - almost exactly your estimate. Here in the States without insurance coverage - the branded medicines would cost nearly $440,000 - breathtaking really. Published pricing is available online at sites such as the following: www.goodrx.com The chance of my insurance covering the costs for retreatment was zero. The current AASLD Guidelines call for deferral of treatment in my case - hardly a surprise considering the drug costs alone (even with their negotiated discounts). My retreatment was a success - SVR4 and SVR12 were both HCV Undetected Could not have done it without your help - the support of the FixHepC Redemption program - and all the folks here that have been my inspiration along the way. I am forever grateful J GT 1a (~1968) Diagnosed Non A/B ’85 – HCV ‘89 Rebetron INF/RBV 17 months 2000 – Failure Infergen INF/RBV 11 months 2002 – Failure Viekira Pak + RBV 12 weeks 2015 – Failure VL Und at +3 weeks > EOT – EOT+12 weeks 2,240k Resistance Tests – NS5a Q30R SMV/DCV/SOF + RBV 24 weeks 2016 VL Det <15 +2 and +4 weeks – Und +8 weeks > EOT SVR4, SVR12 and SVR24 Undetected | |
Options for retreatment 7 years 17 hours ago #24343
Congratulations on SVR12! G3a since '78 - Dx '12 - F4 (2xHCC) 24wk Tx - PEG/Riba/Dac 2013 relapsed 24wk Tx - Generic Sof/Dac/Riba 2015/16 relapsed 16wk Tx - 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof SVR7 - 22/06/17 UND SRV12 - 27/07/17 UND SVR24 - 26/10/17 UND The following user(s) said Thank You: J. Eugene | |
Options for retreatment 7 years 13 hours ago #24345
Congratulations! The insanely high prices for these lifesaving drugs in the US is only surpassed by the insanity of the government that allows them. m This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
Options for retreatment 6 years 11 months ago #24354
Hi J, I can see by your profile what you went through to beat this virus. I'm so so happy that your story has had a happy ending. The cost of treatment that you relay is obscene and prohibitive to so many. Coral G1a probably early 1980's, Biopsy F1(2010), F2-F3(2015). VL 5+mill; 2+mill (2014) Tx naive. Accessed Sof/Led through Dr Freeman at GP2U and Buyers Club (lifesavers!!!) Commenced tx 12/11/15. 9 wk: VL <15 Detected but LFT = Normal 12 week results: UND (Yay!) Due to slow response commenced Sof/Dac 4 Feb for 12 weeks. EOT @ 24 weeks 27 April 2016. (With thanks to Dr Freeman et al). SVR11 result: VL 1,950,000. It's back! New tx 030916 (Viekira Pak, Solvadi, Ribavirin UND @ 111116. EOT 170217. SVR12 and SVR 24 | |
|